CBRN detection, sampling, identification and monitoring capacities and mobile laboratory capacities should be established to respond to low probability risks with a high impact, in accordance with the categories referred to in Article 3d of Implementing Decision (EU) 2019/570 and after consultation with the Member States.
Recital 9, Decision_act (EU) 2022/465
In forcesince 21 Mar 2022